U.S. Pharmacopeia·Jul 18, 2023E&L System Suitability — Finding the Right MixTo ensure USP prioritization of the industry’s most urgent challenges related to extractable and leachable (E&L) impurities screening and…
U.S. Pharmacopeia·Jun 28, 2023Complex generics: The need and challengesThis blog was authored by Prabhakar Gruddanti, Senior Principal Scientist, Science-General Chapters, USP
U.S. Pharmacopeia·Mar 7, 2023What’s driving drug shortages during the cold and flu season?When shock events impact the medicines supply chain, underlying vulnerabilities can cause it to break instead of bend, resulting in drug…
U.S. Pharmacopeia·Jan 31, 2023Omnibus Spending Law: Provisions Will Bolster Medicines Supply Chain Insights and Advanced…Investments to create a more resilient medicines supply chain and prepare for future public health emergencies are among key provisions of…
U.S. Pharmacopeia·Jan 10, 2023USP ensures drug quality from lab to pharmacy shelfThis article was previously published in Chain Drug Review.
U.S. Pharmacopeia·Dec 7, 2022Updated Compounding Standards Help Advance Quality and Support Patient SafetyThis article was authored by Jaap Venema, Executive Vice President, U.S. Pharmacopeia and was originally published on the Quality Matters…
U.S. Pharmacopeia·Dec 2, 2022Drug Manufacturing Innovation: Building In Quality From the Start with USPThis article authored by Dennis Hall, VP, Advanced Manufacturing Technologies, U.S. Pharmacopeia, was originally published on the Quality…
U.S. Pharmacopeia·Dec 1, 2022Latest nitrosamines recall spotlighting need to control pharmaceutical impuritiesThis article authored by Mrunal Jaywant, Vice President R&D at U.S. Pharmacopeia was originally published on the Quality Matters Blog.